References in periodicals archive ?
Its approach, called Progenitor Cell Activation uses combinations of small molecule drugs to activate progenitor cells within the body to create functional tissue.
Bakri, "The role of endothelial progenitor cell in cardiovascular disease risk factors," Acta Medica Indonesiana, vol.
The journal Hypertension Research reported finding an increase in endothelial progenitor cells and a decrease in free radicals in association with supplementation with taurine and magnesium.
Activated adult microglia influence retinal progenitor cell proliferation and differentiation toward recoverin-expressing neuron-like cells in a co-culture model.
Presently, Progenitor Cell Therapy produces ICT-121, a dendritic cell vaccine targeting CD133 cells, in a Phase 1 clinical trial for recurrent glioblastoma multiforme based on a Services Agreement between the firms.
(1) entitled "Endothelial progenitor cells (CD34+KDR+) and monocytes may provide the development of good coronary collaterals despite the vascular risk factors and extensive atherosclerosis." The authors evaluated simultaneously the effects of endothelial progenitor cells (EPC) and inflammatory cells on the presence and the extent of coronary artery disease (CAD) and the grade of coronary collateral growth in patients with clinical suspicion of CAD.
Under the agreement, NeoStem will issue a total of 11.2m ordinary shares and purchase warrants for between 1m and 3m extra shares in exchange for the membership interests of Progenitor Cell Therapy.
Progenitor cell populations in the periodontal ligament of mice.
Said Eigen, "Progenitor Cell Therapy had been planning to relocate from its eurrent location at the Hackensack University Medical Center for over a year, but could not find an existing laboratory facility that met its needs.
Progenitor Cell Therapy is the perfect partner for us due to the importance they have placed on solving the logistical challenges of cell therapy commercialization," said Flora.
At the moment, it seems futuristic to envision therapy with progenitor cell grafts that can survive without proliferation, integrate at appropriate sites, receive innervation, and perform well enough to restore basic mechanoelectrical transduction.
(CBMG) announced that its off-the-shelf allogeneic adipose-derived mesenchymal progenitor cell (haMPC, "AlloJoin") therapy for knee osteoarthritis (KOA) has been approved as the first stem cell KOA drug application in China for a Phase 2 clinical trial.